Kolanus; Waldemar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kolanus; Waldemar.The latest application filed is for "anticancer agent".

Company Profile

0.12.8

Kolanus; Waldemar - Bonn DE
Kolanus; Waldemar - Watertown MA
Kolanus; Waldemar - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors Grant 8,163,788 - Famulok , et al. April 24, 2	2012-04-24
Anticancer Agent App 20110224279 - Kolanus; Waldemar ; et al.	2011-09-15
Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors App 20090105286 - Famulok; Michael ; et al.	2009-04-23
Redirection of cellular immunity by protein tyrosine kinase chimeras Grant 7,320,787 - Seed , et al. January 22, 2	2008-01-22
Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection App 20070287153 - Blind; Michael ; et al.	2007-12-13
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells Grant 7,094,599 - Seed , et al. August 22, 2	2006-08-22
Redirection of cellular immunity by receptor chimeras Grant 7,049,136 - Seed , et al. May 23, 2	2006-05-23
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells Grant 6,753,162 - Seed , et al. June 22, 2	2004-06-22
Methods and compounds for influencing beta3-integrin-dependent intracellular processes App 20040029775 - Gawaz, Meinrad ; et al.	2004-02-12
Redirection Of Cellular Immunity By Receptor Chimeras App 20040005334 - SEED, BRIAN ; et al.	2004-01-08
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells App 20030138410 - Seed, Brian ; et al.	2003-07-24
Redirection of cellular immunity by protein tyrosine kinase chimeras App 20030053994 - Seed, Brian ; et al.	2003-03-20
Redirection of cellular immunity by protein-tyrosine kinase chimeras App 20020176851 - Seed, Brian ; et al.	2002-11-28
Redirection of cellular immunity by protein-tyrosine kinase chimeras Grant 6,410,014 - Seed , et al. June 25, 2	2002-06-25
Redirection of cellular immunity by protein tyrosine kinase chimeras Grant 6,392,013 - Seed , et al. May 21, 2	2002-05-21
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells Grant 6,284,240 - Seed , et al. September 4, 2	2001-09-04
Redirection of cellular immunity by protein tyrosine kinase chimeras Grant 6,004,811 - Seed , et al. December 21, 1	1999-12-21
Redirection of cellular immunity by protein-tyrosine kinase chimeras Grant 5,912,170 - Seed , et al. June 15, 1	1999-06-15
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells Grant 5,851,828 - Seed , et al. December 22, 1	1998-12-22
Redirection of cellular immunity by receptor chimeras Grant 5,843,728 - Seed , et al. December 1, 1	1998-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.